Arfe A - Search Results

1

Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer.

Barnett ES, Schultz N, Stopsack KH, Lam ET, Arfe A, Lee J, Zhao JL, Schonhoft JD, Carbone EA, Keegan NM, Wibmer A, Wang Y, Solit DB, Abida W, Wenstrup R, Scher HI. Barnett ES, et al. Among authors: arfe a. Eur Urol. 2023 Feb;83(2):112-120. doi: 10.1016/j.eururo.2022.08.010. Epub 2022 Sep 16. Eur Urol. 2023. PMID: 36123219 Free PMC article.

2

Validation of Predictive Analyses for Interim Decisions in Clinical Trials.

Avalos-Pacheco A, Ventz S, Arfè A, Alexander BM, Rahman R, Wen PY, Trippa L. Avalos-Pacheco A, et al. Among authors: arfe a. JCO Precis Oncol. 2023 Feb;7:e2200606. doi: 10.1200/PO.22.00606. JCO Precis Oncol. 2023. PMID: 36848613 Free PMC article. Review.

3

Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical Trials in Oncology: Prevalence, Associated Factors, and Implications.

Rahman R, Fell G, Ventz S, Arfé A, Vanderbeek AM, Trippa L, Alexander BM. Rahman R, et al. Among authors: arfe a. Clin Cancer Res. 2019 Nov 1;25(21):6339-6345. doi: 10.1158/1078-0432.CCR-18-3999. Epub 2019 Jul 25. Clin Cancer Res. 2019. PMID: 31345838

4

Meta-Analysis of PD-L1 Expression As a Predictor of Survival After Checkpoint Blockade.

Arfè A, Fell G, Alexander B, Awad MM, Rodig SJ, Trippa L, Schoenfeld JD. Arfè A, et al. JCO Precis Oncol. 2020 Nov;4:1196-1206. doi: 10.1200/PO.20.00150. JCO Precis Oncol. 2020. PMID: 35050777

5

Are generic and brand-name statins clinically equivalent? Evidence from a real data-base.

Corrao G, Soranna D, Arfè A, Casula M, Tragni E, Merlino L, Mancia G, Catapano AL. Corrao G, et al. Among authors: arfe a. Eur J Intern Med. 2014 Oct;25(8):745-50. doi: 10.1016/j.ejim.2014.08.002. Epub 2014 Sep 6. Eur J Intern Med. 2014. PMID: 25200803

6

Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis.

Spring LM, Fell G, Arfe A, Sharma C, Greenup R, Reynolds KL, Smith BL, Alexander B, Moy B, Isakoff SJ, Parmigiani G, Trippa L, Bardia A. Spring LM, et al. Among authors: arfe a. Clin Cancer Res. 2020 Jun 15;26(12):2838-2848. doi: 10.1158/1078-0432.CCR-19-3492. Epub 2020 Feb 11. Clin Cancer Res. 2020. PMID: 32046998 Free PMC article.

7

Shared and Usable Data From Phase 1 Oncology Trials-An Unmet Need.

Arfè A, Ventz S, Trippa L. Arfè A, et al. JAMA Oncol. 2020 Jul 1;6(7):980-981. doi: 10.1001/jamaoncol.2020.0144. JAMA Oncol. 2020. PMID: 32496530 No abstract available.

8

Optimality of testing procedures for survival data in the nonproportional hazards setting.

Arfè A, Alexander B, Trippa L. Arfè A, et al. Biometrics. 2021 Jun;77(2):587-598. doi: 10.1111/biom.13315. Epub 2020 Jun 24. Biometrics. 2021. PMID: 32535892

9

KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials.

Fell G, Redd RA, Vanderbeek AM, Rahman R, Louv B, McDunn J, Arfè A, Alexander BM, Ventz S, Trippa L. Fell G, et al. Among authors: arfe a. Database (Oxford). 2021 Jun 26;2021:baab037. doi: 10.1093/database/baab037. Database (Oxford). 2021. PMID: 34169314 Free PMC article.

10

Master Protocols and Adaptive Trial Designs to Develop Tumor-Agnostic Drugs for Children: Essential Tools in the Era of the Research to Accelerate Cures and Equity Act.

Arfè A, Silverman LB, Bourgeois F. Arfè A, et al. JAMA Oncol. 2021 Sep 1;7(9):1281-1282. doi: 10.1001/jamaoncol.2021.1508. JAMA Oncol. 2021. PMID: 34110376 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters